Kálmán-Szabó, I., Bunda, S., Lihi, N., Szaniszló, Z., Szikra, D., Péli-Szabó, J., Fekete, A., Gyuricza, B., Szücs, D., Papp, G., Trencsényi, G., Kálmán, F.: 61Cu-Labelled radiodiagnostics of melanoma with NAPamide-targeted radiopharmaceutical.
Int. J. Pharm. 632 1-9, 2023.

Péli-Szabó, J., Csige, K., Kálmán-Szabó, I., Arató, V., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Méhes, G., Fenyvesi, F., Hajdu, I., Trencsényi, G.: In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-[béta]-cyclodextrin (HPβCD) using positron emission tomography.
Int. J. Pharm. 630 1-8, 2023.

Kálmán-Szabó, I., Képes, Z., Fekete, A., Vágner, A., Nagy, G., Szücs, D., Gyuricza, B., Arató, V., Varga, J., Kárpáti, L., Garai, I., Mándity, I., Bruchertseifer, F., Elek, J., Szikra, D., Trencsényi, G.: In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
J. Pharm. Biomed. Anal. 229 1-9, 2023.

Csíkos, C., Vágner, A., Nagy, G., Kálmán-Szabó, I., Péli-Szabó, J., Ngo, M., Szoboszlai, Z., Szikra, D., Krasznai, Z., Trencsényi, G., Garai, I.: In Vivo Preclinical Assessment of the VEGF Targeting Potential of the Newly Synthesized [52Mn]Mn-DOTAGA-Bevacizumab Using Experimental Cervix Carcinoma Mouse Model.
Diagnostics. 13 (2), 236-, 2023.

Boda, R., Lázár, I., Keczánné Üveges, A., Bakó, J., Tóth, F., Trencsényi, G., Kálmán-Szabó, I., Béres, M., Sajtos, Z., D. Tóth, E., Deák, Á., Tóth, A., Horváth, D., Gaál, B., Daróczi, L., Dezső, B., Ducza, L., Hegedűs, C.: β-Tricalcium Phosphate-Modified Aerogel Containing PVA/Chitosan Hybrid Nanospun Scaffolds for Bone Regeneration.
Int. J. Mol. Sci. 24 (8), 1-23, 2023.

Képes, Z., Barkóczi, A., Péli-Szabó, J., Kálmán-Szabó, I., Arató, V., Garai, I., Árkosy, P., Jószai, I., Deák, Á., Kertész, I., Hajdu, I., Trencsényi, G.: In Vivo Assessments of Mesoblastic Nephroma (Ne/De) and Myelomonoblastic Leukaemia (My1/De) Tumour Development in Hypercholesterolemia Rat Models.
Int. J. Mol. Sci. 23 (21), 1-16, 2022.

Csige, K., Péli-Szabó, J., Kálmán-Szabó, I., Dénes, N., Szikra, D., Képes, Z., Opposits, G., Méhes, G., Kertész, I., Fenyvesi, F., Trencsényi, G., Hajdu, I.: In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice.
Int. J. Pharm. 625 1-10, 2022.

Képes, Z., Barkóczi, A., Péli-Szabó, J., Kálmán-Szabó, I., Arató, V., Jószai, I., Deák, Á., Kertész, I., Hajdu, I., Trencsényi, G.: In Vivo Preclinical Assessment of β-Amyloid-Affine [11C]C-PIB Accumulation in Aluminium-Induced Alzheimer's Disease-Resembling Hypercholesterinaemic Rat Model.
Int. J. Mol. Sci. 23 1-14, 2022.

Kordován, M., Hegedűs, C., Czifrák, K., Lakatos, C., Kálmán-Szabó, I., Daróczi, L., Zsuga, M., Kéki, S.: Novel Polyurethane Scaffolds Containing Sucrose Crosslinker for Dental Application.
Int. J. Mol. Sci. 23 (14), 1-18, 2022.

Kálmán-Szabó, I., Péli-Szabó, J., Arató, V., Dénes, N., Opposits, G., Jószai, I., Kertész, I., Képes, Z., Fekete, A., Szikra, D., Hajdu, I., Trencsényi, G.: PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
Int. J. Mol. Sci. 23 (17), 1-17, 2022.

Kordován, M., Hegedűs, C., Kálmán-Szabó, I., Czifrák, K., Lakatos, C., Zsuga, M., Kéki, S.: Biokompatibilis építőelemeket tartalmazó poliuretánok előállítása és biológiai vizsgálata = Production and biological testing of polyurethanes containing biocompatible building blocks.
In: XXVII. Nemzetközi Vegyészkonferencia = 27th International Conference on Chemistry. Ed.: Majdik Kornélia, Erdélyi Magyar Műszaki Tudományos Társaság (EMT), online [Kolozsvár], 1, 2021, (ISSN 2734-7109)

Geninatti-Crich, S., Alberti, D., Kálmán-Szabó, I., Aime, S., Djanashvili, K.: Cover Picture: MRI Visualization of Melanoma Cells by Targeting Overexpressed Sialic Acid with a Gd(III)-dota-en-pba Imaging Reporter (Angew. Chem. Int. Ed. 4/2013).
Angew. Chem.-Int. Edit. 52 (4), 1057-1334, 2013.

Geninatti-Crich, S., Alberti, D., Kálmán-Szabó, I., Aime, S., Djanashvili, K.: MRI Visualization of Melanoma Cells by Targeting Overexpressed Sialic Acid with a GdIII-dota-en-pba Imaging Reporter.
Angew. Chem.-Int. Edit. 52 (4), 1161-1164, 2013.

Geninatti-Crich, S., Cutrin, J., Lanzardo, S., Kálmán, F., Kálmán-Szabó, I., Lago, N., Iolascon, A., Aime, S.: Mn-loaded apoferritin: a highly sensitive MRI imaging probe for the detection and characterization of hepatocarcinoma lesions in a transgenic mouse model.
Contrast. Media Mol. Imaging. 7 (3), 281-288, 2012.

Kálmán-Szabó, I., Crich, S., Alberti, D., Kálmán, F., Aime, S.: Mn loaded apoferritin as an MRI sensor of melanin formation in melanoma cells.
Chem. Commun. 48 (18), 2436-2438, 2012.

Geninatti-Crich, S., Alberti, D., Kálmán-Szabó, I., Deagostino, A., Toppino, A., Barge, A., Ballarini, F., Bortolussi, S., Bruschi, P., Protti, N., Stella, S., Altieri, S., Venturello, P., Aime, S.: MRI-Guided Neutron Capture Therapy by Use of a Dual Gadolinium/Boron Agent Targeted at Tumour Cells through Upregulated Low-Density Lipoprotein Transporters.
Chem.-Eur. J. 17 (30), 8479-8486, 2011.

Geninatti-Crich, S., Kálmán-Szabó, I., Alberti, D., Longo, D., Aime, S.: MRI of cells and mice at 1 and 7?Tesla with Gd-targeting agents: when the low field is better!.
Contrast Media Mol. Imaging. 6 (6), 421-425, 2011.

Crivello, A., Nervi, C., Gobetto, R., Geninatti-Crich, S., Kálmán-Szabó, I., Barge, A., Toppino, A., Deagostino, A., Venturello, P., Aime, S.: Towards improved boron neutron capture therapy agents: evaluation of in vitro cellular uptake of a glutamine-functionalized carborane.
J. Biol. Inorg. Chem. 14 (6), 883-890, 2009.

Stefania, R., Tei, L., Barge, A., Geninatti-Crich, S., Kálmán-Szabó, I., Cabella, C., Cravotto, G., Aime, S.: Tuning Glutamine Binding Modes in Gd-DOTA-Based Probes for an Improved MRI Visualization of Tumor Cells.
Chem. Eur. J. 15 76-85, 2009.